NASDAQ:BRKR - Bruker Stock Price, News & Analysis

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker declared a quarterly dividend on Monday, August 12th. Shareholders of record on Tuesday, September 3rd will be paid a dividend of $0.04 per share on Friday, September 20th. This represents a $0.16 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date is Friday, August 30th. View Bruker's Dividend History.

Bruker Co. (NASDAQ:BRKR) issued its quarterly earnings results on Thursday, August, 1st. The medical research company reported $0.33 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.02. The medical research company had revenue of $490.20 million for the quarter, compared to the consensus estimate of $477.70 million. Bruker had a net margin of 9.57% and a return on equity of 27.10%. The firm's revenue was up 10.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.25 EPS. View Bruker's Earnings History.

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for Bruker.

Bruker issued an update on its FY19 earnings guidance on Thursday, August, 1st. The company provided earnings per share (EPS) guidance of $1.57-1.61 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.62. The company issued revenue guidance of $2.028-2.048 billion, compared to the consensus revenue estimate of $2.04 billion.

11 brokerages have issued 1-year target prices for Bruker's shares. Their forecasts range from $32.00 to $57.00. On average, they anticipate Bruker's share price to reach $49.20 in the next year. This suggests a possible upside of 18.6% from the stock's current price. View Analyst Price Targets for Bruker.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 4 hold ratings, 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.

News headlines about BRKR stock have trended negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Bruker earned a coverage optimism score of -2.3 on InfoTrie's scale. They also assigned media coverage about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Bruker.

Bruker saw a decrease in short interest in July. As of July 31st, there was short interest totalling 1,715,200 shares, a decrease of 16.2% from the June 30th total of 2,046,400 shares. Based on an average daily trading volume, of 859,700 shares, the short-interest ratio is presently 2.0 days. Approximately 1.7% of the shares of the stock are sold short. View Bruker's Current Options Chain.

Some companies that are related to Bruker include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Avantor (AVTR), PerkinElmer (PKI), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include Advanced Micro Devices (AMD), Thermo Fisher Scientific (TMO), Abbott Laboratories (ABT), Ciena (CIEN), General Electric (GE), Costco Wholesale (COST), Cisco Systems (CSCO), Illumina (ILMN), Intel (INTC) and Netflix (NFLX).

Bruker's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (19.20%), Vanguard Group Inc. (6.93%), BlackRock Inc. (3.32%), Acadian Asset Management LLC (2.40%), Janus Henderson Group PLC (2.13%) and Janus Henderson Group PLC (2.13%). Company insiders that own Bruker stock include Frank H Laukien, Marc A Kastner and Mark Munch. View Institutional Ownership Trends for Bruker.

BRKR stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Acadian Asset Management LLC, Point72 Asset Management L.P., Marshall Wace North America L.P., BNP Paribas Arbitrage SA, Allianz Asset Management GmbH, Russell Investments Group Ltd. and Man Group plc. Company insiders that have sold Bruker company stock in the last year include Frank H Laukien and Marc A Kastner. View Insider Buying and Selling for Bruker.

BRKR stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Nuveen Asset Management LLC, APG Asset Management N.V., First Trust Advisors LP, Sector Gamma AS, Price T Rowe Associates Inc. MD, Los Angeles Capital Management & Equity Research Inc. and Vanguard Group Inc.. View Insider Buying and Selling for Bruker.

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BRKR stock can currently be purchased for approximately $41.47.

Bruker has a market capitalization of $6.41 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.View Additional Information About Bruker.

The official website for Bruker is http://www.bruker.com/.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]